Elimor Brand-Schieber, PhD

Scientific Director, Clinical Development Neuroscience
AbbVie
Madison, New Jersey

Disclosure information not submitted.

Presentation(s):

• Efficacy of Ubrogepant for the Treatment of Migraine Symptoms During the Prodrome (Premonitory Phase): Results From the PRODROME Trial

  POSTER ABSTRACT